Weekender 1/29/16

As we prepare to honor New Jersey’s Innovators that received drug approvals in 2015 at our upcoming Annual Dinner Meeting on February 4, the Garden State is off to a strong start again in 2016 with drug approvals over the last week going to BioNJ Members Genmab, Eli Lilly, Merck, Allergan and Bristol-Myers Squibb. Congrats!

Meanwhile, a dozen BioNJ Members were named to the annual NJBIZ Power 100 list, including BioNJ President and CEO, Debbie Hart.

Congratulations to Rutgers Business School for being named #1 nationally for placing MBAs in the healthcare industry, which includes the biopharma industry.
See you next Thursday at BioNJ’s Annual Dinner Meeting. We can’t wait!
Click here to read this week’s Weekender.